<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem. Eng.</journal-id>
<journal-title>Frontiers in Chemical Engineering</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem. Eng.</abbrev-journal-title>
<issn pub-type="epub">2673-2718</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1097215</article-id>
<article-id pub-id-type="doi">10.3389/fceng.2022.1097215</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemical Engineering</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Recombinant yeast for production of the pain receptor modulator nonivamide from vanillin</article-title>
<alt-title alt-title-type="left-running-head">Muratovska and Carlquist</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fceng.2022.1097215">10.3389/fceng.2022.1097215</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Muratovska</surname>
<given-names>Nina</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2100391/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Carlquist</surname>
<given-names>Magnus</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/967143/overview"/>
</contrib>
</contrib-group>
<aff>
<institution>Division of Applied Microbiology</institution>, <institution>Department of Chemistry</institution>, <institution>Faculty of Engineering</institution>, <institution>Lund University</institution>, <addr-line>Lund</addr-line>, <country>Sweden</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1824267/overview">Vasudeo Zambare</ext-link>, University of Technology Malaysia, Malaysia</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/234372/overview">Jingwen Zhou</ext-link>, Jiangnan University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/767493/overview">Xue Cai</ext-link>, Zhejiang University of Technology, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Magnus Carlquist, <email>magnus.carlquist@tmb.lth.se</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Biochemical Engineering, a section of the journal Frontiers in Chemical Engineering</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>4</volume>
<elocation-id>1097215</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>12</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Muratovska and Carlquist.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Muratovska and Carlquist</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>We report on the development of a method based on recombinant yeast <italic>Saccharomyces cerevisiae</italic> to produce nonivamide, a capsaicinoid and potent agonist of the pain receptor TRPV1. Nonivamide was produced in a two-step batch process where yeast was i) grown aerobically on glucose and ii) used to produce nonivamide from vanillin and non-anoic acid by bioconversion. The yeast was engineered to express multiple copies of an amine transaminase from <italic>Chromobacterium violaceum</italic> (CvTA), along with an NADH-dependent alanine dehydrogenase from <italic>Bacillus subtilis</italic> (BsAlaDH) to enable efficient reductive amination of vanillin<italic>.</italic> Oxygen-limited conditions and the use of ethanol as a co-substrate to regenerate NADH were identified to favour amination over the formation of the by-products vanillic alcohol and vanillic acid. The native alcohol dehydrogenase ADH6 was deleted to further reduce the formation of vanillic alcohol. A two-enzyme system consisting of an <italic>N</italic>-acyltransferase from <italic>Capsicum annuum</italic> (CaAT), and a CoA ligase from <italic>Sphingomonas</italic> sp. Ibu-2 (IpfF) was co-expressed to produce the amide. This study provides proof of concept for yeast-based production of non-ivamide by combined transamination and amidation of vanillin.</p>
</abstract>
<kwd-group>
<kwd>recombinant yeast</kwd>
<kwd>reductive amination</kwd>
<kwd>vanillin</kwd>
<kwd>nonivamide</kwd>
<kwd>capsaicin</kwd>
<kwd>pain modulator</kwd>
<kwd>TRPV1</kwd>
<kwd>amide formation</kwd>
</kwd-group>
<contract-sponsor id="cn001">Vetenskapsr&#xe5;det<named-content content-type="fundref-id">10.13039/501100004359</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Capsaicinoids are plant alkaloids with strong agonist activity on TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1). They have several applications in the food industry, e.g. for colouring, seasoning and flavour enhancement, and in the pharmaceutical industry, especially for their anti-inflammatory and analgesic properties (<xref ref-type="bibr" rid="B1">Baenas et al., 2019</xref>; <xref ref-type="bibr" rid="B13">Koivisto et al., 2021</xref>). Production in chili pepper is impacted by pre- and post-harvest factors, such as environmental, genotypical and storage conditions, which affect the amount and composition of the capsaicinoids (<xref ref-type="bibr" rid="B29">Uarrota et al., 2021</xref>). The development of a fermentation process with metabolically engineered yeast may enable more efficient production compared to the plant (<xref ref-type="bibr" rid="B19">Muratovska et al., 2022b</xref>). Baker&#x2019;s yeast, <italic>Saccharomyces cerevisiae</italic>, is a well-known production host within industrial microbiology and several methods have been developed recently for its use to biosynthesize natural products such as terpenoids (cannabinoids), flavonoids and betalains (<xref ref-type="bibr" rid="B26">Romero-Suarez et al., 2022</xref>).</p>
<p>In the plant, capsaicinoid biosynthesis involves the phenylpropanoid pathway to vanillylamine (derived from vanillin), and the fatty acid synthesis pathway to CoA-activated fatty acid, which are condensed by an amide-forming <italic>N</italic>-acyltransferase (capsaicin synthase) (<xref ref-type="bibr" rid="B22">Ogawa et al., 2015</xref>). <italic>De novo</italic> biosynthesis of capsaicinoids in yeast has to date not been developed and would require functional expression of several heterologous genes and re-routing of endogenous biochemical pathways. Previously, yeast has been engineered to produce vanillin and vanillin glycoside from sugar <italic>via</italic> the shikimic acid pathway (<xref ref-type="bibr" rid="B9">Hansen et al., 2009</xref>; <xref ref-type="bibr" rid="B28">Strucko et al., 2015</xref>). There are also examples of engineered yeast for production of medium-chain fatty acids (<xref ref-type="bibr" rid="B6">Gajewski et al., 2017</xref>; <xref ref-type="bibr" rid="B36">Zhu et al., 2020</xref>). Yeast expression of <italic>N</italic>-acyltransferase and CoA-ligase from <italic>Capsicum annuum</italic> (CaAT) (<xref ref-type="bibr" rid="B11">Kang et al., 2005</xref>) and <italic>Sphingomonas</italic> sp. Ibu-2 (IpfF) (<xref ref-type="bibr" rid="B20">Murdoch and Hay, 2013</xref>), respectively, was recently shown to enable production of nonivamide (a model capsaicinoid) from supplemented vanillylamine and non-anoic acid (<xref ref-type="bibr" rid="B18">Muratovska et al., 2022a</xref>), as the last step in capsaicinoid synthesis.</p>
<p>A key step in the pathway is the reductive amination of vanillin to form vanillylamine, which has not been shown previously in yeast. The reaction is hampered by an unfavourable thermodynamic equilibrium that lies in the direction of the aldehyde when using endogenous amine donors (such as <italic>L</italic>-alanine); however, this can be influenced by several strategies. Vanillin aminotransaminase from <italic>Capsicum sp</italic>. (<xref ref-type="bibr" rid="B34">Weber et al., 2014b</xref>), as well as <italic>Chromobacterium violaceum</italic> amine transaminase (CvTA), have been shown to be functional in yeast. However, these have only been applied for whole-cell production of chiral amines by kinetic resolution of racemic amines (amine to ketone), since the reverse direction (ketone to amine) has been proven to be exceptionally difficult to achieve <italic>in vivo</italic> (<xref ref-type="bibr" rid="B33">Weber et al., 2014a</xref>; <xref ref-type="bibr" rid="B34">Weber et al., 2014b</xref>; <xref ref-type="bibr" rid="B12">Knudsen et al., 2016</xref>; <xref ref-type="bibr" rid="B35">Weber et al., 2017</xref>). This was though recently achieved for vanillylamine production in engineered <italic>Escherichia coli</italic> (<xref ref-type="bibr" rid="B5">Fu et al., 2021</xref>) and <italic>Pseudomonas putida</italic> (<xref ref-type="bibr" rid="B16">Manfrao-Netto et al., 2021</xref>), both expressing CvTA and alanine dehydrogenase from <italic>Bacillus subtilis</italic> (BsAlaDH) (<xref ref-type="bibr" rid="B14">Koszelewski et al., 2008</xref>). Key to success was the co-expression of CvTA and BsAlaDH in combination with appropriate reaction conditions in favour of amine formation. The transaminase reaction competes with endogenous activity of alcohol dehydrogenases and reductases resulting in conversion of vanillin to the by-products vanillic acid, and vanillic alcohol (<xref ref-type="bibr" rid="B31">Wang et al., 2018</xref>). Therefore, a strategy to suppress formation of these is necessary. In yeast, the deletion of alcohol dehydrogenase 6 (ADH6) was previously shown to decrease (but not totally remove) formation of vanillic alcohol in strains engineered to produce vanillin-glucoside (<xref ref-type="bibr" rid="B9">Hansen et al., 2009</xref>). Another strategy to suppress the activity of NADPH-dependent vanillin reductases and not affect reductive amination, which are typically dependent on regeneration of NADH, may be to selectively reduce NADPH regeneration. This strategy has previously been applied in yeast to selectively favour NADH-dependent reductases over competing NADPH-dependent enzymes, thereby improving stereoselectivity of whole-cell bioreduction of ketones to chiral alcohols (<xref ref-type="bibr" rid="B15">Kratzer et al., 2008</xref>).</p>
<p>Here, yeast strains co-expressing CvTA, BsAlaDH, CaAT and IpF, and with deleted ADH6 were constructed and evaluated for reductive amination and amidation of vanillin (<xref ref-type="fig" rid="F1">Figure 1</xref>). The use of glucose and ethanol as co-substrate were compared under both aerobic and anaerobic conditions to determine environmental conditions favouring the formation of vanillylamine over the alcohol and acid by-products. Using a combination of genetic and process engineering we demonstrate the use of yeast for production of nonivamide from supplemented vanillin and non-anoic acid in well controlled bioreactors.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Production of nonivamide from non-anoic acid and vanillin in recombinant yeast overexpressing IpfF (<italic>Spingomonas</italic> sp. Ibu-2 CoA-ligase), CaAT (<italic>Capsicum annuum N</italic>-acyltransferase), CvTA (<italic>Chromobacterium violaceum</italic> amine transaminase) and BsAlaDH (<italic>Bacillus subtilis</italic> alanine dehydrogenase), and with deleted ADH6 (alcohol dehydrogenase 6). The by-products vanillyl acid and vanillic alcohol formed by endogenous enzymes VDH (vanillin dehydrogenase), and ADH6 (and other oxidoreductases), respectively, are suppressed under oxygen-limited conditions and with ethanol as co-substrate to regenerate NADH.</p>
</caption>
<graphic xlink:href="fceng-04-1097215-g001.tif"/>
</fig>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Material and methods</title>
<sec id="s2-1">
<title>2.1 Strains and media</title>
<p>
<italic>Saccharomyces cerevisiae</italic> strains were maintained on Yeast Peptone Dextrose (YPD) medium (20&#xa0;g L<sup>&#x2212;1</sup> peptone, 10&#xa0;g L<sup>&#x2212;1</sup> yeast extract, 20&#xa0;g L<sup>&#x2212;1</sup> glucose; 20&#xa0;g L<sup>&#x2212;1</sup> agar for plates). Geneticin (200&#xa0;mg L<sup>&#x2212;1</sup>) and nourseothricin (100&#xa0;mg L<sup>&#x2212;1</sup>) were supplemented in the media when needed for selection of Cas9 (KanMX) and gRNA (natMX) plasmids, respectively. Sub-cloning was done in electro-competent <italic>Escherichia coli</italic> DH5&#x3b1;. Lysogeny Broth (LB) medium (10&#xa0;g L<sup>&#x2212;1</sup> tryptone, 5&#xa0;g L<sup>&#x2212;1</sup> yeast extract, 10&#xa0;g L<sup>&#x2212;1</sup> NaCl; 15&#xa0;g L<sup>&#x2212;1</sup> agar for plates) with 100&#xa0;mg L<sup>&#x2212;1</sup> ampicillin was used for <italic>E. coli</italic> liquid cultivation and selection on solid plates. All strains were stored in 25% (v/v) glycerol at &#x2212;80&#xb0;C. Defined mineral medium (<xref ref-type="bibr" rid="B30">Verduyn et al., 1992</xref>) was used as basis for the bioconversions, buffered at pH 6.5.</p>
</sec>
<sec id="s2-2">
<title>2.2 Plasmid and strain constructions</title>
<p>Strains and plasmids used in this work are listed in <xref ref-type="table" rid="T1">Table 1</xref>. Standard molecular biology methods were used (<xref ref-type="bibr" rid="B37">Sambrook and Russell, 2001</xref>). Preparative and diagnostic PCR for genome engineering was performed using Physion and DreamTaq polymerase (Thermo Scientific, US), respectively. All modifications were verified by colony PCR using primers listed in <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>. Primers were designed using SnapGene<sup>&#xae;</sup> (GSL Biotech LLC. Version 3.03, US) and purchased from Eurofins (Eurofins Genomics, Germany). Agarose (0.8%) gel electrophoresis was used for estimating size of the DNA fragments. All plasmids (<xref ref-type="table" rid="T1">Table 1</xref>) were purified using GeneJet plasmid MiniPrep Kit (Thermo Scientific, US) after propagation in <italic>E. coli</italic>. Alanine dehydrogenase gene (Genbank ID 936557) from <italic>Bacillus subtilis</italic> (<italic>BsAlaDH</italic>) was codon optimized for expression in <italic>S. cerevisiae</italic> and obtained in a pUC57 vector (Genescript, US). <italic>BsAlaDH</italic> gene was amplified with primers flanked with restriction sites SfaAI/XhoI and subsequently cloned into pRP005 between TEF1p promotor and ADH1t terminator flanked by homologous regions for chromosomal integration, generating pNM011. pNM012 was constructed by cloning TEF1p into the backbone plasmid pCfB3034. Correct DNA sequence of constructed plasmids were verified by Sanger sequencing (Eurofins Genomics, Germany). <italic>S. cerevisiae</italic> strains were engineered by the previously described CRISPR-Cas9 toolkit (<xref ref-type="bibr" rid="B10">Jessop-Fabre et al., 2016</xref>). The lithium acetate-based protocol (<xref ref-type="bibr" rid="B8">Gietz and Schiestl, 2007</xref>) with the addition of DMSO for improving cell permeability, was used for generating competent yeast cells. TMB4375 strain carrying six copies of <italic>Chromobacterium violaceum</italic> amine transaminase gene (<italic>CvTA</italic>) (<xref ref-type="bibr" rid="B35">Weber et al., 2017</xref>) was transformed with the pCfB2312 plasmid, carrying <italic>Streptococcus pyogenes</italic> gene, SpCas9, and used as background strain for the strain engineering. Transformation with a linearized pNM011 (using NotI restriction enzyme) and pCfB3045 (gRNA) plasmid generated strain TMBNM032. Deletion of <italic>ADH6</italic> was achieved by transforming TMBNM032 with a PCR product carrying <italic>AUR</italic> gene cassette for aureobasidin A (AurA) resistance and &#x223c;50bp homologous flanks to the target locus, generating strain TMBNM033. Transformants resistant to AurA were selected in solid medium and correct gene knockout was analysed with diagnostic PCR. Codon optimized genes coding for CaAT (Tyramine <italic>N</italic>-(hydroxycinnamoyl) transferase from <italic>Capsicum annum,</italic> and IpfF (Ibuprofen CoA ligase from <italic>Sphingomonas</italic> sp. Ibu-2)) were integrated using a method developed previously (<xref ref-type="bibr" rid="B18">Muratovska et al., 2022a</xref>), generating strain TMBNM034 (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Strains and plasmids used in the study.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">
<italic>S. cerevisiae</italic> strains</th>
<th align="left">Description</th>
<th align="left">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">TMB4375</td>
<td align="left">
<italic>CEN.PK2-1C MAT</italic> <bold>a</bold> <italic>ura3-52 MAL2-8&#xa0;C SUC2, TRP1, LEU2, HIS3;</italic> pNW12 (6x), <italic>TDH</italic>3p-<italic>CVTA</italic>-<italic>ADH1</italic>t</td>
<td align="left">
<xref ref-type="bibr" rid="B35">Weber et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left">TMBNM032</td>
<td align="left">TMB4375; <italic>TEF1</italic>p-<italic>AlaDH</italic>-<italic>ADH1t</italic>
</td>
<td align="left">This study</td>
</tr>
<tr>
<td align="left">TMBNM033</td>
<td align="left">TMBNM032; &#x394;ADH6:<italic>AurR</italic>
</td>
<td align="left">This study</td>
</tr>
<tr>
<td align="left">TMBNM034</td>
<td align="left">TMBNM033; <italic>TEF1</italic>p-<italic>IpfF</italic>-<italic>PGK1</italic>t; <italic>GDP</italic>p-<italic>CaAT</italic>-<italic>ADH1</italic>
</td>
<td align="left">This study</td>
</tr>
</tbody>
</table>
<table>
<thead valign="top">
<tr>
<th align="left">
<italic>Plasmids</italic>
</th>
<th align="left">Description</th>
<th align="left">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">pCfB2312</td>
<td align="left">
<italic>TEF1</italic>p-<italic>Cas9</italic>-<italic>CYC1</italic>t_kanMX, Episomal plasmid for Cas9 expression</td>
<td align="left">
<xref ref-type="bibr" rid="B10">Jessop-Fabre et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">pUC57-AlaDH</td>
<td align="left">pUC57::<italic>ald</italic>, AmpR</td>
<td align="left">
<xref ref-type="bibr" rid="B16">Manfrao-Netto et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">pCfB2904</td>
<td align="left">XI-3 MarkerFree backbone</td>
<td align="left">
<xref ref-type="bibr" rid="B10">Jessop-Fabre et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">pCfB3034</td>
<td align="left">X-3 MarkerFree backbone</td>
<td align="left">
<xref ref-type="bibr" rid="B10">Jessop-Fabre et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">pCfB3045</td>
<td align="left">gRNA sequence for targeting XI-3, natMX</td>
<td align="left">
<xref ref-type="bibr" rid="B10">Jessop-Fabre et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">pNW12</td>
<td align="left">YIpOB7<italic>::TDH</italic>3p-<italic>CVTA</italic>-<italic>ADH1</italic>t, <italic>URA3</italic>, AmpR</td>
<td align="left">
<xref ref-type="bibr" rid="B35">Weber et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left">pRP005</td>
<td align="left">pCfB2904; <italic>TEF1</italic>p-<italic>yEGFP3</italic>-<italic>ADH1</italic>t</td>
<td align="left">
<xref ref-type="bibr" rid="B24">Perruca-Foncillas et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">pNM001</td>
<td align="left">pUC57; AmpR; <italic>TEF1</italic>p-<italic>ACS</italic>-<italic>PGK1</italic>t; <italic>GDP</italic>p-<italic>AT3</italic>-<italic>ADH1</italic>t</td>
<td align="left">
<xref ref-type="bibr" rid="B18">Muratovska et al. (2022a)</xref>
</td>
</tr>
<tr>
<td align="left">pNM006</td>
<td align="left">pUC57mini::<italic>CaAT</italic>, AmpR</td>
<td align="left">
<xref ref-type="bibr" rid="B18">Muratovska et al. (2022a)</xref>
</td>
</tr>
<tr>
<td align="left">pNM009</td>
<td align="left">pUC57mini::<italic>IpfF</italic>, AmpR</td>
<td align="left">
<xref ref-type="bibr" rid="B18">Muratovska et al. (2022a)</xref>
</td>
</tr>
<tr>
<td align="left">pNM011</td>
<td align="left">pRP005; <italic>TEF1</italic>p-<italic>ald</italic>-<italic>ADH1</italic>p</td>
<td align="left">This study</td>
</tr>
<tr>
<td align="left">pNM012</td>
<td align="left">pCfB3034::<italic>TEF1</italic>p</td>
<td align="left">This study</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-3">
<title>2.3 Whole-cell bioconversion in shake flasks and serum vials</title>
<p>Pre-cultures were prepared from a single colony in 5&#xa0;ml YPD grown overnight. Shake flask with 25&#xa0;mL defined mineral medium (<xref ref-type="bibr" rid="B30">Verduyn et al., 1992</xref>) and glucose (20&#xa0;g L<sup>&#x2212;1</sup>) was inoculated to initial optical density (OD<sub>620nm</sub>) &#x223c;0.5 and incubated at 30&#xb0;C in 180&#xa0;rpm shaking incubator for 24&#x2013;26&#xa0;h to generate biomass. Subsequently, yeast cells were harvested by centrifugation at 3220&#xa0;<italic>g</italic> for 10&#xa0;min (Eppendorf Centrifuge 5810 R, Germany) and re-suspended at OD<sub>620nm</sub> &#x223c;5 in 50&#xa0;mL of reaction medium. The reaction medium was based on defined mineral medium buffered at 6.5 pH, and supplemented with vanillin (5&#xa0;mM), glucose (10&#xa0;g L<sup>&#x2212;1</sup>) or ethanol (0.5 or 10&#xa0;g L<sup>&#x2212;1</sup>) as co-substrate, and with or without <italic>L</italic>-alanine (50&#xa0;mM) and ammonium chloride (200&#xa0;mM) as nitrogen source. Whole-cell bioconversions were performed under aerobic or anaerobic conditions. For the aerobic conditions, bioconversions were carried out in 500&#xa0;mL shake flasks containing 50&#xa0;mL medium and incubated at 30&#xb0;C in 180&#xa0;rpm shaking incubator as described above. Anaerobic bioconversions were performed in sealed serum vials containing 50&#xa0;mL medium and sparged with nitrogen gas for 1&#xa0;h before the start of the reaction and incubated at 30&#xb0;C in 180&#xa0;rpm shaking incubator.</p>
</sec>
<sec id="s2-4">
<title>2.4 Batch bioreactor cultivations</title>
<p>Pre-cultures were prepared from a single colony inoculated in a shake flask with 50&#xa0;mL defined mineral medium incubated under shaking (180&#xa0;rpm) at 30&#xb0;C for around 24&#xa0;h. The pre-culture was used to inoculate 3&#xa0;L bench-top bioreactor (Minifors 2. Infors HT, Bottmingen, Switzerland) at OD<sub>620nm</sub> &#x3d; 0.1 in 1&#xa0;L of defined mineral medium with 50&#xa0;g L<sup>&#x2212;1</sup> glucose. The pH was kept at 6.5 by automated addition of 3&#xa0;M KOH, the stirring was constant at 300&#xa0;rpm, and the temperature was set at 30&#xb0;C. Yeast cells were first grown under aerobic conditions with air sparging set to 500&#xa0;ml/min (0.5&#xa0;vvm) for approximately 20&#xa0;h, and the whole-cell bioconversions were subsequently started by adding the substrates (vanillin and non-anoic acid) to the media. For the non-sparged condition, aeration was stopped to achieve oxygen-limited conditions after the initial growth phase, and directly prior to the supplementation of substrates.</p>
</sec>
<sec id="s2-5">
<title>2.5 Analytical methods</title>
<p>Samples were collected with a syringe regularly from cell cultures for analysis of yeast cell concentration, yeast cell viability, and extracellular metabolite analysis. Yeast cell concentration was estimated by measuring optical density at 620&#xa0;nm (OD<sub>620nm</sub>) with a spectrophotometer (Ultrospec 2,100 pro UV/Visible spectrophotometer, Amersham Biosciences, Buckinghamshire, United Kingdom). Yeast cell viability was monitored by flow cytometry (Accuri C&#x2b;, BD, US) using the fluorescent dyes SYBR Green I and propidium iodide, as described previously (<xref ref-type="bibr" rid="B25">Rao et al., 2021</xref>). Instrument settings were adjusted to the following: medium flow rate, FSC-H threshold at 80,000, and acquisition of 10,000 events. FCM data analysis was made with FlowJo<sup>&#xae;</sup> (United States). Gating of yeast cells was based on FSC-H and SSC-H signals to distinguish cells from background noise, and gating of damaged and intact cells were based on SYBR Green I detected with FL1-H (530/30&#xa0;nm), and PI detected with FL3-H (&#x2265;670&#xa0;nm) signals. Yeast cells treated with 70% ethanol for 30&#xa0;min were used as control to identify damaged cells and to adjust the gates. For the analysis of glucose, ethanol, glycerol and acetate, a Waters HPLC system equipped with an Aminex HPX-87 H ion-exchange column (7.8 &#xd7; 300&#xa0;mm, Bio-Rad, Hercules, United States), and a refractive index detector (Waters 2,414, Milford, United States) were used, as described previously (<xref ref-type="bibr" rid="B34">Weber et al., 2014b</xref>). The mobile phase was 5&#xa0;mM H<sub>2</sub>SO<sub>4</sub> with a flow rate of 0.6&#xa0;mL/min, and the column was kept at 60&#xb0;C. For reverse-phase HPLC analysis of vanillin, vanillylamine, vanillic alcohol and vanillic acid, a Select C18 column (4.6 &#xd7; 150&#xa0;mm) with mobile phase consisting of ultrapure water and 0.1% trifluoroacetic acid (TFA) (A) and acetonitrile (B). The method was isocratic with 65% A and 35% B for 10&#xa0;min with a flow of 1&#xa0;ml min<sup>&#x2212;1</sup>, at room temperature and the monitored wavelength was at 281&#xa0;nm, as described previously (<xref ref-type="bibr" rid="B16">Manfrao-Netto et al., 2021</xref>). Prior to HPLC analysis of nonivamide, product extraction was performed from 20&#xa0;ml samples from the bioreactors. Supernatant was collected after centrifugation at 3220&#xa0;<italic>g</italic> for 10&#xa0;min, transferred to an extraction funnel and extracted with one volume of ethyl acetate. The organic phase was collected and evaporated using a rotary vacuum evaporator. The resulting viscous oil was dissolved in 1&#xa0;mL of methanol and HPLC analysis were performed using the same Select C18 column (4.6 &#xd7; 150&#xa0;mm) as previously described (<xref ref-type="bibr" rid="B18">Muratovska et al., 2022a</xref>).</p>
</sec>
<sec id="s2-6">
<title>2.6 Calculations</title>
<p>The <italic>rate ratio</italic> is defined as the vanillylamine formation rate (mmol h<sup>-1</sup>) divided by the by-product (vanillic alcohol and vanillic acid) formation rate (mmol h<sup>-1</sup>) for the initial 6&#xa0;h. <italic>Molar yield</italic> is defined as moles of product (vanillylamine) or by-product (vanillic alcohol or vanillic acid) per moles of consumed substrate (vanillin) after 48&#xa0;h. The specific <italic>vanillylamine productivity</italic> (&#xb5;mol OD<sup>&#x2212;1</sup> h<sup>&#x2212;1</sup>) is calculated for the initial 6&#xa0;h.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 Comparison of reaction conditions for reductive amination with yeast over-expressing CvTA</title>
<p>Yeast carrying six copies of the CvTA gene expressed under control of the strong constitutive TDH3 promoter was evaluated under different reaction conditions for whole-cell conversion of vanillin to vanillylamine (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). Most vanillin reductases are NADPH-dependent, and vanillin dehydrogenase is NAD &#x2b; -dependent; therefore, the redox balance significantly influence by-product formation. In Crabtree positive yeast, such as <italic>Saccharomyces cerevisiae</italic>, glucose is readily fermented to ethanol in both aerobic and anaerobic conditions, while ethanol is slowly respired in aerobic condition and stays practically inert in anaerobic condition (<xref ref-type="bibr" rid="B2">De Deken, 1966</xref>). The availability of NADPH is limited with the use of ethanol as co-substrate, especially under anaerobic condition resulting in suppression of the activity of NADPH-dependent reductases (but not NADH-dependent reductases) (<xref ref-type="bibr" rid="B15">Kratzer et al., 2008</xref>). In contrast, NADPH is efficiently regenerated in the pentose phosphate pathway during glucose assimilation (<xref ref-type="bibr" rid="B23">Parachin et al., 2009</xref>). Another important factor is the abundance of pyruvate formed both as central carbon metabolite and from the amine donor <italic>L</italic>-alanine in yeast (<xref ref-type="bibr" rid="B34">Weber et al., 2014b</xref>; <xref ref-type="bibr" rid="B35">Weber et al., 2017</xref>). Pyruvate is a strong inhibitor of CvTA and its removal shifts the equilibrium to the amine (<xref ref-type="bibr" rid="B27">S&#xe1;nchez-Moreno et al., 2012</xref>; <xref ref-type="bibr" rid="B35">Weber et al., 2017</xref>). Here, four conditions were evaluated: (i) aerobic with glucose as carbon source, (ii) aerobic with ethanol as carbon source, (iii) anaerobic with glucose as carbon source, and (iv) anaerobic with ethanol as carbon source. Pre-cultures were made in the same way and whole-cell bioconversions were performed at relatively high cell density (OD<sub>620nm</sub> &#x3d; 5); therefore, the expression level of endogenous genes was the same at start of the reaction, and any differences in product spectra would be due to the specific applied reaction environment. Significant differences were observed for the different conditions, with the highest vanillin consumption rate (0.11 &#xb1; 0.00&#xa0;mmol OD<sup>&#x2212;1</sup> h<sup>&#x2212;1</sup>) under aerobic conditions and with ethanol used as a co-substrate (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). This condition resulted in more production of vanillylamine (3.21 &#xb1; 0.56&#xa0;mM) compared to the rest, but also of the by-products vanillic alcohol (4.11 &#xb1; 1.48&#xa0;mM) and vanillic acid (1.72 &#xb1; 0.40&#xa0;mM) (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). To compare the activity of CvTA and endogenous enzymes acting on vanillin, the rate ratio, defined as vanillylamine formation rate per by-product formation rate, was calculated (<xref ref-type="table" rid="T2">Table 2</xref>). A higher rate ratio (5-7- fold) was observed with ethanol as co-substrate, both under aerobic and anaerobic condition. The difference in rate ratio under aerobic conditions was mostly due to an increased formation of vanillylamine with the use of ethanol as the co-substrate. A significant amount of vanillic alcohol and vanillic acid was formed for both glucose and ethanol as co-substrate under aerobic conditions, which was expected due to balanced levels of NAD(P)H/NAD(P)&#x2b; ratios under respiration (<xref ref-type="bibr" rid="B21">Murray et al., 2011</xref>). Under anaerobic conditions, the transamination was less efficient, however, alcohol and acid formation were also significantly lower. Worth noting is the almost complete suppression of vanillic acid formation under anaerobic conditions, possibly due to low availability of NAD<sup>&#x2b;</sup>, or NADP<sup>&#x2b;</sup> (<xref ref-type="sec" rid="s10">Supplementary Figure S1C, D</xref>). In aerobic conditions, the vanillin consumption rate was generally faster, regardless on the choice of co-substrate; however, which end products were formed from vanillin depend on the choice of co-substrate and oxygen availability.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Process parameters calculated for the different reaction conditions and strains during whole-cell conversion of vanillin to vanillylamine (VA).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Aerobicity</th>
<th align="left">Co-substrate</th>
<th align="left">VA productivity (&#xb5;mol OD<sup>&#x2212;1</sup> h<sup>&#x2212;1</sup>)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</th>
<th align="left">VA titre (mM)</th>
<th align="left">VA yield (mol/mol)<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</th>
<th align="left">Rate ratio<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="6" align="center">Strain TMB4375</td>
</tr>
<tr>
<td rowspan="2" align="left">Aerobic (O2)</td>
<td align="left">Glucose (10&#xa0;g/L)</td>
<td align="left">14.20 &#xb1; 0.49</td>
<td align="left">2.12 &#xb1; 1.34</td>
<td align="left">0.15 &#xb1; 0.05</td>
<td align="left">0.27 &#xb1; 0.05</td>
</tr>
<tr>
<td align="left">Ethanol (10&#xa0;g/L)</td>
<td align="left">63.86 &#xb1; 7.82</td>
<td align="left">3.21 &#xb1; 0.56</td>
<td align="left">0.42 &#xb1; 0.06</td>
<td align="left">1.57 &#xb1; 0.10</td>
</tr>
<tr>
<td rowspan="2" align="left">Anaerobic (N2)</td>
<td align="left">Glucose (10&#xa0;g/L)</td>
<td align="left">7.79 &#xb1; 3.55</td>
<td align="left">1.83 &#xb1; 0.04</td>
<td align="left">0.44 &#xb1; 0.01</td>
<td align="left">0.23 &#xb1; 0.16</td>
</tr>
<tr>
<td align="left">Ethanol (10&#xa0;g/L)</td>
<td align="left">8.49 &#xb1; 0.97</td>
<td align="left">1.54 &#xb1; 0.35</td>
<td align="left">0.71 &#xb1; 0.44</td>
<td align="left">1.78 &#xb1; 0.97</td>
</tr>
<tr>
<td colspan="6" align="center">Strain TMBNM032</td>
</tr>
<tr>
<td rowspan="2" align="left"> Aerobic (O2)</td>
<td align="left">Glucose (10&#xa0;g/L)</td>
<td align="left">16.72 &#xb1; 0.37</td>
<td align="left">1.97 &#xb1; 1.10</td>
<td align="left">0.15 &#xb1; 0.05</td>
<td align="left">0.31 &#xb1; 0.05</td>
</tr>
<tr>
<td align="left">Ethanol (10&#xa0;g/L)</td>
<td align="left">60.77 &#xb1; 1.86</td>
<td align="left">2.99 &#xb1; 0.53</td>
<td align="left">0.37 &#xb1; 0.04</td>
<td align="left">1.48 &#xb1; 0.00</td>
</tr>
<tr>
<td rowspan="2" align="left"> Anaerobic (N2)</td>
<td align="left">Glucose (10&#xa0;g/L)</td>
<td align="left">10.81 &#xb1; 2.84</td>
<td align="left">3.23 &#xb1; 0.04</td>
<td align="left">0.46 &#xb1; 0.02</td>
<td align="left">0.28 &#xb1; 0.13</td>
</tr>
<tr>
<td align="left">Ethanol (10&#xa0;g/L)</td>
<td align="left">20.21 &#xb1; 6.17</td>
<td align="left">4.29 &#xb1; 0.16</td>
<td align="left">0.83 &#xb1; 0.10</td>
<td align="left">4.86 &#xb1; 0.00</td>
</tr>
<tr>
<td colspan="6" align="center">Strain TMBNM032</td>
</tr>
<tr>
<td rowspan="2" align="left">Aerobic (O2)</td>
<td align="left">Glucose (10&#xa0;g/L)</td>
<td align="left">12.33 &#xb1; 4.18</td>
<td align="left">2.24 &#xb1; 0.14</td>
<td align="left">0.37 &#xb1; 0.07</td>
<td align="left">0.55 &#xb1; 0.20</td>
</tr>
<tr>
<td align="left">Ethanol (10&#xa0;g/L)</td>
<td align="left">51.81 &#xb1; 7.49</td>
<td align="left">4.41 &#xb1; 1.34</td>
<td align="left">0.57 &#xb1; 0.07</td>
<td align="left">3.52 &#xb1; 2.40</td>
</tr>
<tr>
<td rowspan="4" align="left">Anaerobic (N2)</td>
<td align="left">Glucose (10&#xa0;g/L)</td>
<td align="left">13.07 &#xb1; 11.22</td>
<td align="left">3.10 &#xb1; 0.08</td>
<td align="left">0.58 &#xb1; 0.05</td>
<td align="left">0.77 &#xb1; 0.08</td>
</tr>
<tr>
<td align="left">Ethanol (10&#xa0;g/L)</td>
<td align="left">24.24 &#xb1; 6.27</td>
<td align="left">2.10 &#xb1; 0.01</td>
<td align="left">0.94 &#xb1; 0.25</td>
<td align="left">12.29 &#xb1; 0.00</td>
</tr>
<tr>
<td align="left">Ethanol (10&#xa0;g/L) <xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<italic>no alanine</italic>
</td>
<td align="left">30.59 &#xb1; 1.97</td>
<td align="left">3.65 &#xb1; 0.12</td>
<td align="left">0.96 &#xb1; 0.02</td>
<td align="left">
<italic>no by-products</italic>
</td>
</tr>
<tr>
<td align="left">Ethanol (0.5&#xa0;g/L) <xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<italic>no alanine</italic>
</td>
<td align="left">26.88 &#xb1; 1.00</td>
<td align="left">3.20 &#xb1; 0.51</td>
<td align="left">0.92 &#xb1; 0.03</td>
<td align="left">
<italic>no by-products</italic>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>
<sup>a</sup>
</label>
<p>Productivity (&#xb5;mol OD<sup>&#x2212;1</sup> h<sup>&#x2212;1</sup>) calculated for the initial 6&#xa0;h.</p>
</fn>
<fn id="Tfn2">
<label>
<sup>b</sup>
</label>
<p>Yield (mol vanillylamine/mol consumed vanillin) after 48&#xa0;h.</p>
</fn>
<fn id="Tfn3">
<label>
<sup>c</sup>
</label>
<p>Vanillylamine formation rate per by-product formation rate.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The highest molar yield of vanillylamine was reached under the anaerobic condition with ethanol as co-substrate (0.71 &#xb1; 0.44&#xa0;mol/mol), while the lowest molar yield of vanillylamine per consumed vanillin after 48&#xa0;h was on glucose in the aerobic condition (0.15 &#xb1; 0.05&#xa0;mol/mol) (<xref ref-type="table" rid="T2">Table 2</xref>). However, a problem during the anaerobic condition was incomplete conversion of vanillin. A reason for this could be inhibition of the transaminase by pyruvate accumulation, or low limitation in amine donor availability. Alanine was supplied in excess and gets converted to pyruvate by both CvTA, as well as by endogenous transaminases, for example by alanine transaminase (encoded by ALT1) (<xref ref-type="bibr" rid="B7">Garc&#xed;a-Campusano et al., 2009</xref>). Pyruvate could be removed from the reaction system through conversion to ethanol by pyruvate decarboxylase and alcohol dehydrogenase. During respiration, pyruvate is converted to acetyl-CoA by pyruvate dehydrogenase, and further oxidised in the tricarboxylic acid (TCA) cycle to CO<sub>2</sub> and generating NADH (<xref ref-type="bibr" rid="B4">Flikweert et al., 1996</xref>). When glucose is present during the bioconversion, there would be higher intracellular pyruvate levels (<xref ref-type="bibr" rid="B34">Weber et al., 2014b</xref>; <xref ref-type="bibr" rid="B35">Weber et al., 2017</xref>), which could explain why conditions with ethanol gave better transamination yields.</p>
</sec>
<sec id="s3-2">
<title>3.2 Co-expression of BsAlaDH with the CvTA improves vanillylamine production</title>
<p>To relieve potential pyruvate inhibition and improve the amine donor supply, an NADH-dependant alanine dehydrogenase from <italic>Bacillus subtilis,</italic> BsAlaDH, was expressed in strain TMBNM032 under control of the TEF1 promoter. Co-expression of CvTA and BsAlaDH resulted in almost complete conversion of vanillin within 48&#xa0;h (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>), which could indicate that pyruvate accumulation and/or alanine limitation was the issue in the parent strain TMB4375. Vanillin consumption rate for this strain as well as the vanillylamine titres after 48&#xa0;h was almost double when compared to strain TMB4375 in the anaerobic conditions (<xref ref-type="table" rid="T2">Table 2</xref>; <xref ref-type="sec" rid="s10">Supplementary Figures S1C, D</xref> vs. <xref ref-type="sec" rid="s10">Supplementary Figures S2A, B</xref>). The rate ratios (vanillylamine formed per by-products formed) were not noticeably different compared to TMB4375 (<xref ref-type="table" rid="T2">Table 2</xref>), except under anaerobic conditions with ethanol as co-substrate (4.86 rate ratio) Here, only low amounts of vanillic alcohol were detected after 48&#xa0;h (0.9 mM; <xref ref-type="sec" rid="s10">Supplementary Figure S2B</xref>). Compared to TMB4375 in the same condition, the formation of vanillic alcohol decreased with the expression of AlaDH by around a third, and the vanillylamine yields were increased from 0.71 to 0.83&#xa0;mol/mol (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<sec id="s3-2-1">
<title>3.2.1 Deleted ADH6 reduce formation of vanillic alcohol</title>
<p>Adh6 is an alcohol dehydrogenase with activity to both NADH and NADPH, shown previously to be largely responsible for the reduction of vanillin in yeast (<xref ref-type="bibr" rid="B9">Hansen et al., 2009</xref>; <xref ref-type="bibr" rid="B32">Wang et al., 2016</xref>). To further decrease the levels of vanillic alcohol, deletion of ADH6 was made in strain TMBNM033. In our hands, and in agreement with previous studies, the ADH6 deletion strain produced less vanillic alcohol with both glucose (3-fold less) or ethanol as co-substrate (4-fold less) than the control strain (<xref ref-type="table" rid="T2">Table 2</xref>; <xref ref-type="fig" rid="F2">Figures 2A,B</xref>). The yield of vanillylamine per consumed vanillin was higher in all cases, with the highest molar yield (0.94 &#xb1; 0.25) reached in anaerobic condition with ethanol as co-substrate. The largest difference in rate ratio was observed under anaerobic condition with ethanol as co-substrate (12.3 compared to 4.9). However, under these conditions the amination of vanillin arrested around 20&#xa0;h, resulting in incomplete conversion. This indicates that NADH regeneration is limiting under these conditions, which on one hand may reduce NADH-dependent reduction of vanillin from endogenous reductases, and on the other also reduce the desired conversion of pyruvate to alanine by BsAlaDH.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Anaerobic whole-cell bioconversions of vanillin to vanillylamine with yeast strain TMBNM033, co-expressing CvTA and BsAlaDH, and with deleted ADH6. Reactions were made in serum vials sparged with nitrogen using defined mineral medium supplemented with <bold>(A)</bold> glucose and alanine; <bold>(B)</bold> 10&#xa0;g L<sup>&#x2212;1</sup> ethanol and alanine, <bold>(C)</bold> 10&#xa0;g L<sup>&#x2212;1</sup> ethanol, and without alanine, or <bold>(D)</bold> 0.5&#xa0;g L<sup>&#x2212;1</sup> ethanol and without alanine. Co-substrates glucose (black diamond) or ethanol (dotted line with grey circle) are shown on the left axis, and the metabolites vanillin (green circle), vanillylamine (red square) and vanillic alcohol (black triangle) are shown on the right axis.</p>
</caption>
<graphic xlink:href="fceng-04-1097215-g002.tif"/>
</fig>
</sec>
<sec id="s3-2-2">
<title>3.2.2 Omitting alanine in the reaction broth improves vanillylamine production</title>
<p>Alanine is typically added in excess in biocatalytic transamination but may instead be produced <italic>de novo</italic>. In recombinant <italic>P. putida</italic> expressing CvTA and BsAlaDH, the omission of alanine resulted in improved reductive amination of vanillin, possibly due to reduced amount of intracellular pyruvate originating from the activity of endogenous alanine transaminases (<xref ref-type="bibr" rid="B16">Manfrao-Netto et al., 2021</xref>). To see if the same hold for recombinant yeast expressing the same CvTA and BsAlaDH, whole-cell bioconversions were performed with and without alanine with strain TMBNM033 (<xref ref-type="fig" rid="F2">Figures 2C, D</xref>). The reaction was performed under anaerobic condition with ethanol as co-substrate since these conditions were found to suppress formation of vanillic alcohol and vanillic acid. The omission of alanine indeed had a noticeable positive effect on the titre and yield of vanillylamine (<xref ref-type="fig" rid="F2">Figures 2C, D</xref>), in agreement with the results for <italic>P. putida</italic> (<xref ref-type="bibr" rid="B16">Manfrao-Netto et al., 2021</xref>). In fact, under these conditions the highest vanillylamine titre (3.65&#xa0;mM) and yield from consumed vanillin (0.96&#xa0;mol/mol) were obtained (<xref ref-type="table" rid="T2">Table 2</xref>). This further demonstrates that the alanine dehydrogenase efficiently converts pyruvate to alanine and drives the transamination reaction without external supplementation of amine donor.</p>
</sec>
<sec id="s3-2-3">
<title>3.2.3 Assimilation of ethanol as co-substrate correlates to the amination reaction</title>
<p>As mentioned before, amination of vanillin was favoured over alcohol formation the most with ethanol supplemented as a co-substrate and having anaerobic condition during the bioconversion, although the reaction arrested completely halfway through. <italic>S. cerevisiae</italic> generally cannot metabolise ethanol anaerobically because it requires the TCA and glyoxylate cycles and the electron transport chain. However, some ethanol could be converted to acetate <italic>via</italic> acetaldehyde by alcohol dehydrogenase EC 1.1.1.1 (ex. Adh1) and acetaldehyde dehydrogenase EC 1.2.1.3 (ex Ald6) (<xref ref-type="bibr" rid="B17">Meaden et al., 1997</xref>; <xref ref-type="bibr" rid="B3">de Smidt et al., 2008</xref>). This route enabled regeneration of NADH for AlaDH for ca 20&#xa0;h, after which the formation of vanillylamine stopped (<xref ref-type="fig" rid="F2">Figure 2C</xref>). To better see to which degree ethanol was converted during the progression of the reaction, 0.5&#xa0;g L<sup>&#x2212;1</sup> ethanol instead of 10&#xa0;g L<sup>&#x2212;1</sup> was used, thereby enabling the detection of an even minute decrease through HPLC analysis (<xref ref-type="fig" rid="F2">Figure 2D</xref>). The ethanol titre indeed decreased under the first 25&#xa0;h from 0.40 to 0.27&#xa0;g L<sup>&#x2212;1</sup>, or with 32%, and then it remained constant. Ethanol consumption thus coincided with the conversion of vanillin to vanillylamine, proving its importance as co-substrate for supplying reducing equivalents to the reduction reaction. Vanillic alcohol was however not detected in this condition and the vanillylamine yield was high (0.92&#xa0;mol/mol), demonstrating the transamination being the dominant activity (<xref ref-type="table" rid="T2">Table 2</xref>). The arrest in ethanol assimilation, and thereby of the amination reaction, may be due to accumulation of intracellular acetaldehyde, which is inhibitory to yeast cells. Further studies could be directed to fine-tune the co-substrate for improved NADH availability for the BsAlaDH to produce higher amount of alanine (and less of pyruvate), and still avoid vanillic alcohol formation.</p>
</sec>
</sec>
<sec id="s3-3">
<title>3.3 Combined reductive amination and amidation for nonivamide production</title>
<p>Strain TMBNM033 was further engineered by expressing CaAT and IpfF, previously shown to be effective in the biosynthesis of nonivamide from non-anoic acid and vanillylamine (<xref ref-type="bibr" rid="B18">Muratovska et al., 2022a</xref>). The constructed yeast strain TMBNM034, containing CvTA, BsAlaDH, &#x394;ADH6 and CaAT/IpfF, was characterised in bench scale bioreactors for production of nonivamide from vanillin and non-anoic acid (<xref ref-type="fig" rid="F3">Figure 3</xref>). The yeast cells were first grown under aerobic conditions with glucose as carbon and energy source; subsequently, the substrates vanillin and non-anoic acid were added. At this point, the cell density was high (OD<sub>620nm</sub> &#x3d; 15&#x2013;17) enabling higher conversion rates. Aeration was found to affect the whole-cell transamination reaction negatively, both in terms of vanillylamine formation, and by-product formation (<xref ref-type="table" rid="T2">Table 2</xref>). On the other hand, lack of oxygen may result in limited supply of ATP and CoA-SH required for the coenzyme A ligase to generate the acyl-coa for the amide-forming step. To shed light into this possible dilemma, two reaction configurations were compared: (1) air-sparged conditions (<xref ref-type="fig" rid="F3">Figures 3A, B</xref>) and (2) non-sparged oxygen-limited conditions (<xref ref-type="fig" rid="F3">Figures 3C, D</xref>). The supplied vanillin and non-anoic acid were converted to nonivamide in both cases, but slightly more in the presence of oxygen (0.19 vs. 0.12&#xa0;&#x3bc;mol&#xa0;L<sup>&#x2212;1</sup> OD<sup>&#x2212;1</sup>) (<xref ref-type="fig" rid="F3">Figure 3</xref>; <xref ref-type="table" rid="T3">Table 3</xref>). The results demonstrate that amidation indeed can be combined with reductive amination in one-pot in yeast. However, nonivamide titers were low and a significant accumulation of vanillylamine (3&#x2013;5&#xa0;mM) was observed, showing that the amide-forming step is the bottleneck for production from vanillin. It may be speculated that increasing the amount of air in the bioreactor may improve the situation by increasing the supply of ATP and CoA-SH; however, other problems may also be at hand, <italic>e.g.</italic> CaAT, and IpfF expression levels or the specific activity of the enzymes may be low. Also, the availability of non-anoic acid may be limiting since it is supplemented in low concentration due to toxicity and low solubility (<xref ref-type="bibr" rid="B18">Muratovska et al., 2022a</xref>). The experiments indicate that the <italic>in vivo</italic> transamination reaction is hampered by increased aeration of the reaction broth. The rate ratio of vanillylamine formation per by-product formation was higher under non-sparged conditions (3.5 vs. 2.4). Formation of vanillic alcohol and even more so, of vanillic acid, were lower, resulting in molar yields from consumed vanillin of 0.28 &#xb1; 0.03 and 0.03 &#xb1; 0.01&#xa0;at 48&#xa0;h respectively. This shows that the ADH6 deletion is not sufficient to completely prevent vanillic alcohol formation under the applied conditions. Nevertheless, while ethanol assimilation was not detected under anaerobic condition, it was consumed throughout the bioconversion sparged with air, indicating functional regeneration of cofactors. Cell viability, measured by flow cytometry, remained high throughout the bioconversions with &#x3e;98% intact cells for both conditions (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref> in supplementary), and could not explain the observed differences in activity.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Bioreactor controlled whole-cell bioconversion of vanillin and non-anoic acid to nonivamide by yeast strain TMBNM034, co-expressing CvTA, BsAlaDH, CaAT/IpfF and with deleted ADH6. During the first 20&#xa0;h both bioreactor set-ups were treated in the same way, after which (marked with vertical line) vanillin and non-anoic acid were added and aeration was kept at 0.5&#xa0;vvm <bold>(A, B)</bold> or stopped <bold>(C, D)</bold>. Left axis presents measured fermentation metabolites glucose (black diamond), ethanol (dotted line with grey circle), acetate (empty blue triangle), glycerol (empty yellow circle) shown in g&#xa0;L<sup>&#x2212;1</sup> <bold>(A, C)</bold>; and bioconversion metabolites vanillin (green circle), vanillylamine (red square), vanillic alcohol (black triangle), vanillic acid (black empty square) shown in mM <bold>(B, D)</bold>. Right axes present OD<sub>620nm</sub> [dotted line with black cross; <bold>(A, C)</bold>] or nonivamide in &#xb5;M [orange dotted line with circle; <bold>(B, D)</bold>].</p>
</caption>
<graphic xlink:href="fceng-04-1097215-g003.tif"/>
</fig>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Yield, rates and titers calculated for the combined amination and amidation for nonivamide production in bioreactor set-up.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">TMBNM034</th>
<th colspan="3" align="left">Yield (mol/mol)<xref ref-type="table-fn" rid="Tfn4">
<sup>a</sup>
</xref>
</th>
<th rowspan="2" align="left">Rate ratio<xref ref-type="table-fn" rid="Tfn5">
<sup>b</sup>
</xref>
</th>
<th rowspan="2" align="left">Nonivamide titre (&#xb5;M)</th>
<th rowspan="2" align="left">Nonivamide productivity (&#xb5;mol L<sup>&#x2212;1</sup> OD<sup>&#x2212;1</sup>)</th>
</tr>
<tr>
<th align="left">Condition</th>
<th align="left">Vanillyl amine</th>
<th align="left">Vanillic alcohol</th>
<th align="left">Vanillic acid</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Oxygen limited</td>
<td align="left">0.74 &#xb1; 0.02</td>
<td align="left">0.28 &#xb1; 0.03</td>
<td align="left">0.03 &#xb1; 0.01</td>
<td align="left">2.42 &#xb1; 0.35</td>
<td align="left">3.45 &#xb1; 0.76</td>
<td align="left">0.19 &#xb1; 0.05</td>
</tr>
<tr>
<td align="left">No aeration</td>
<td align="left">0.89 &#xb1; 0.07</td>
<td align="left">0.23 &#xb1; 0.01</td>
<td align="left">0.00 &#xb1; 0.00</td>
<td align="left">3.92 &#xb1; 0.20</td>
<td align="left">1.44 &#xb1; 0.31</td>
<td align="left">0.12 &#xb1; 0.02</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn4">
<label>
<sup>a</sup>
</label>
<p>Product per consumed vanillin after 48&#xa0;h.</p>
</fn>
<fn id="Tfn5">
<label>
<sup>b</sup>
</label>
<p>Vanillylamine formation rate per by-product formation rate after 48&#xa0;h.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>
<italic>S. cerevisiae</italic> was engineered for production of nonivamide from vanillin and non-anoic acid. The constructed yeast strain contains a multienzyme cascade for carrying out coupled amine and amide forming steps <italic>in vivo</italic>. Over-expression of CvTA and the NADH-dependent BsAlaDH together with ADH6 knockout, and the use of ethanol as co-substrate and oxygen-limitation to regenerate mainly NADH favoured formal reductive amination and led to an almost complete suppression of endogenous enzymes converting vanillin to vanillic acid and vanillic alcohol. The amide forming step using the CaAT/IpfF-cascade was two to three orders of magnitude less efficient than the amination, still, functionality was clear. The developed method opens the possibility for yeast-based production of capsaicinoids from vanillin, although more efforts are needed to improve efficiency.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>NM performed the experiments, analysis and drafted the manuscript. NM and MC conceived the study, designed the experiments, interpreted the data, and wrote the manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>The study was financed by the Swedish Research Council under Grant 201704174.</p>
</sec>
<ack>
<p>We acknowledge the members of the Microbial Engineering Group at the department of chemistry, Lund university, for fruitful discussions during preparation of this manuscript. We would like to thank Raquel Perruca-Foncillas for providing the pRP005 plasmid.</p>
</ack>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fceng.2022.1097215/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fceng.2022.1097215/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baenas</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Belovi&#x107;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ilic</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Viguera</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Industrial use of pepper (Capsicum annum L.) derived products: Technological benefits and biological advantages</article-title>. <source>Food Chem.</source> <volume>274</volume>, <fpage>872</fpage>&#x2013;<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2018.09.047</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Deken</surname>
<given-names>R. H.</given-names>
</name>
</person-group> (<year>1966</year>). <article-title>The crabtree effect: A regulatory system in yeast</article-title>. <source>J. Gen. Microbiol.</source> <volume>44</volume> (<issue>2</issue>), <fpage>149</fpage>&#x2013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-44-2-149</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Smidt</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>du Preez</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Albertyn</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The alcohol dehydrogenases of <italic>Saccharomyces cerevisiae</italic>: A comprehensive review</article-title>. <source>FEMS Yeast Res.</source> <volume>8</volume> (<issue>7</issue>), <fpage>967</fpage>&#x2013;<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1111/j.1567-1364.2008.00387.x</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flikweert</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Van Der Zanden</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Steensma</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Van Dijken</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Pronk</surname>
<given-names>J. T.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Pyruvate decarboxylase: An indispensable enzyme for growth of <italic>Saccharomyces cerevisiae</italic> on glucose</article-title>. <source>Yeast</source> <volume>12</volume> (<issue>3</issue>), <fpage>247</fpage>&#x2013;<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-0061(19960315)12:3%3C247:AID-YEA911%3E3.0.CO;2-I</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Renewable vanillylamine synthesis from lignin-derived feedstocks</article-title>. <source>ACS Agric. Sci. Technol.</source> <volume>1</volume> (<issue>5</issue>), <fpage>566</fpage>&#x2013;<lpage>571</lpage>. <pub-id pub-id-type="doi">10.1021/acsagscitech.1c00174</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gajewski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pavlovic</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boles</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Grininger</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Engineering fungal de novo fatty acid synthesis for short chain fatty acid production</article-title>. <source>Nat. Commun.</source> <volume>8</volume>, <fpage>14650</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms14650</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garc&#xed;a-Campusano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Anaya</surname>
<given-names>V.-H.</given-names>
</name>
<name>
<surname>Robledo-Arratia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Quezada</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Riego</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>ALT1-encoded alanine aminotransferase plays a central role in the metabolism of alanine in <italic>Saccharomyces cerevisiae</italic>
</article-title>. <source>Can. J. Microbiol.</source> <volume>55</volume> (<issue>4</issue>), <fpage>368</fpage>&#x2013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1139/w08-150</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gietz</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Schiestl</surname>
<given-names>R. H.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method</article-title>. <source>Nat. Protoc.</source> <volume>2</volume> (<issue>1</issue>), <fpage>31</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2007.13</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Kock</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Bunner</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Kristensen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>O. R.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>De novo biosynthesis of vanillin in fission yeast (<italic>Schizosaccharomyces pombe</italic>) and baker&#x27;s yeast (<italic>Saccharomyces cerevisiae</italic>)</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>75</volume> (<issue>9</issue>), <fpage>2765</fpage>&#x2013;<lpage>2774</lpage>. <comment>AEM.02681-08 [pii]</comment>. <pub-id pub-id-type="doi">10.1128/AEM.02681-08</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jessop-Fabre</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Jakociunas</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Stovicek</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Keasling</surname>
<given-names>J. D.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>EasyClone-MarkerFree: A vector toolkit for marker-less integration of genes into <italic>Saccharomyces cerevisiae</italic> via CRISPR-cas9</article-title>. <source>Biotechnol. J.</source> <volume>11</volume> (<issue>8</issue>), <fpage>1110</fpage>&#x2013;<lpage>1117</lpage>. <pub-id pub-id-type="doi">10.1002/biot.201600147</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D.-S.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Functional analysis of the amine substrate specificity domain of pepper tyramine and serotonin N-hydroxycinnamoyltransferases</article-title>. <source>Plant Physiol.</source> <volume>140</volume> (<issue>2</issue>), <fpage>704</fpage>&#x2013;<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1104/pp.105.071514</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knudsen</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>H&#xe4;ggl&#xf6;f</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gorwa-Grauslund</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Increased availability of NADH in metabolically engineered baker&#x2019;s yeast improves transaminase-oxidoreductase coupled asymmetric whole-cell bioconversion</article-title>. <source>Microb. Cell. Fact.</source> <volume>5</volume>, <fpage>37</fpage>. <pub-id pub-id-type="doi">10.1186/s12934-016-0430-x</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koivisto</surname>
<given-names>A.-P.</given-names>
</name>
<name>
<surname>Belvisi</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Gaudet</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Szallasi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Advances in TRP channel drug discovery: From target validation to clinical studies</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>21</volume>, <fpage>41</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1038/s41573-021-00268-4</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koszelewski</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lavandera</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Clay</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Guebitz</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Rozzell</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kroutil</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Formal asymmetric biocatalytic reductive amination</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source> <volume>47</volume> (<issue>48</issue>), <fpage>9337</fpage>&#x2013;<lpage>9340</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200803763</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kratzer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Egger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nidetzky</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Integration of enzyme, strain and reaction engineering to overcome limitations of baker&#x27;s yeast in the asymmetric reduction of alpha-keto esters</article-title>. <source>Biotechnol. Bioeng.</source> <volume>101</volume> (<issue>5</issue>), <fpage>1094</fpage>&#x2013;<lpage>1101</lpage>. <pub-id pub-id-type="doi">10.1002/bit.21980</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manfrao-Netto</surname>
<given-names>J. H. C.</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Muratovska</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Parachin</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Carlquist</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Metabolic engineering of Pseudomonas putida for production of vanillylamine from lignin-derived substrates</article-title>. <source>Microb. Biotechnol.</source> <volume>14</volume>, <fpage>2448</fpage>&#x2013;<lpage>2462</lpage>. <pub-id pub-id-type="doi">10.1111/1751-7915.13764</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meaden</surname>
<given-names>P. G.</given-names>
</name>
<name>
<surname>Dickinson</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Mifsud</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tessier</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Westwater</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bussey</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>1997</year>). <article-title>The ALD6 gene of <italic>Saccharomyces cerevisiae</italic> encodes a cytosolic, Mg(2&#x2b;)-activated acetaldehyde dehydrogenase</article-title>. <source>Yeast</source> <volume>13</volume> (<issue>14</issue>), <fpage>1319</fpage>&#x2013;<lpage>1327</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-0061(199711)13:14&#x3c;1319:AID-YEA183&#x3e;3.0.CO;2-T</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muratovska</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Grey</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Carlquist</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022a</year>). <article-title>Engineering <italic>Saccharomyces cerevisiae</italic> for production of the capsaicinoid nonivamide</article-title>. <source>Microb. Cell. Factories</source> <volume>21</volume>, <fpage>106</fpage>. <pub-id pub-id-type="doi">10.1186/s12934-022-01831-3</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muratovska</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pozdniakova</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Grey</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Johansson</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Towards engineered yeast as production platform for capsaicinoids</article-title>. <source>Biotechnol. Adv.</source> <volume>59</volume>, <fpage>107989</fpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2022.107989</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murdoch</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Hay</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Genetic and chemical characterization of ibuprofen degradation by Sphingomonas Ibu-2</article-title>. <source>Microbiol. Read.</source> <volume>159</volume> (<issue>3</issue>), <fpage>621</fpage>&#x2013;<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.062273-0</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Haynes</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tomita</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Redox regulation in respiring <italic>Saccharomyces cerevisiae</italic>
</article-title>. <source>Biochimica Biophysica Acta (BBA) - General Subj.</source> <volume>1810</volume> (<issue>10</issue>), <fpage>945</fpage>&#x2013;<lpage>958</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2011.04.005</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Murota</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shimura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Furuya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Togawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Matsumura</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Evidence of capsaicin synthase activity of the Pun1-encoded protein and its role as a determinant of capsaicinoid accumulation in pepper</article-title>. <source>BMC Plant Biol.</source> <volume>15</volume>, <fpage>93</fpage>. <pub-id pub-id-type="doi">10.1186/s12870-015-0476-7</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parachin</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Carlquist</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gorwa-Grauslund</surname>
<given-names>M. F.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Comparison of engineered <italic>Saccharomyces cerevisiae</italic> and engineered <italic>Escherichia coli</italic> for the production of an optically pure keto alcohol</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>84</volume> (<issue>3</issue>), <fpage>487</fpage>&#x2013;<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-009-1964-1</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perruca-Foncillas</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Davidsson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Carlquist</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gorwa-Grauslund</surname>
<given-names>M. F.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Assessment of fluorescent protein candidates for multi-color flow cytometry analysis of <italic>Saccharomyces cerevisiae</italic>
</article-title>. <source>Biotechnol. Rep.</source> <volume>34</volume>, <fpage>e00735</fpage>. <pub-id pub-id-type="doi">10.1016/j.btre.2022.e00735</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Lundberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Palmkron</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hakansson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bergenstahl</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Carlquist</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Flow cytometric analysis reveals culture condition dependent variations in phenotypic heterogeneity of Limosilactobacillus reuteri</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>23567</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-02919-3</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romero-Suarez</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Keasling</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Supplying plant natural products by yeast cell factories</article-title>. <source>Curr. Opin. Green Sustain. Chem.</source> <volume>33</volume>, <fpage>100567</fpage>. <pub-id pub-id-type="doi">10.1016/j.cogsc.2021.100567</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Sambrook</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>D. W.</given-names>
</name>
</person-group> (<year>2001</year>). <source>Molecular cloning: A laboratory manual</source>. <publisher-loc>Cold Spring Harbour</publisher-loc>: <publisher-name>Cold Spring Harbour Laboratory Press</publisher-name>.</citation>
</ref>
<ref id="B27">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>S&#xe1;nchez-Moreno</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Oroz-Guinea</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Iturrate</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Junceda</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2012</year>). &#x201c;<article-title>7.20 multi-enzyme reactions</article-title>,&#x201d; in <source>Comprehensive chirality</source>. Editors <person-group person-group-type="editor">
<name>
<surname>Carreira</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>H.</given-names>
</name>
</person-group> (<publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name>), <fpage>430</fpage>&#x2013;<lpage>453</lpage>.</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strucko</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Magdenoska</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Mortensen</surname>
<given-names>U. H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Benchmarking two commonly used <italic>Saccharomyces cerevisiae</italic> strains for heterologous vanillin-&#x3b2;-glucoside production</article-title>. <source>Metab. Eng. Commun.</source> <volume>2</volume>, <fpage>99</fpage>&#x2013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/j.meteno.2015.09.001</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uarrota</surname>
<given-names>V. G.</given-names>
</name>
<name>
<surname>Maraschin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>de Bairros</surname>
<given-names>&#xc2;. d. F. M.</given-names>
</name>
<name>
<surname>Pedreschi</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Factors affecting the capsaicinoid profile of hot peppers and biological activity of their non-pungent analogs (Capsinoids) present in sweet peppers</article-title>. <source>Crit. Rev. Food Sci. Nutr.</source> <volume>61</volume> (<issue>4</issue>), <fpage>649</fpage>&#x2013;<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2020.1743642</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verduyn</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Postma</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Scheffers</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Van Dijken</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Effect of benzoic acid on metabolic fluxes in yeasts: A continuous-culture study on the regulation of respiration and alcoholic fermentation</article-title>. <source>Yeast</source> <volume>8</volume> (<issue>7</issue>), <fpage>501</fpage>&#x2013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1002/yea.320080703</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Kuang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Functions of aldehyde reductases from <italic>Saccharomyces cerevisiae</italic> in detoxification of aldehyde inhibitors and their biotechnological applications</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>102</volume> (<issue>24</issue>), <fpage>10439</fpage>&#x2013;<lpage>10456</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-018-9425-3</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Identification and functional evaluation of the reductases and dehydrogenases from <italic>Saccharomyces cerevisiae</italic> involved in vanillin resistance</article-title>. <source>BMC Biotechnol.</source> <volume>16</volume> (<issue>1</issue>), <fpage>31</fpage>. <pub-id pub-id-type="doi">10.1186/s12896-016-0264-y</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gorwa-Grauslund</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carlquist</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2014a</year>). <article-title>Engineered baker&#x27;s yeast as whole-cell biocatalyst for one-pot stereo-selective conversion of amines to alcohols</article-title>. <source>Microb. Cell. Fact.</source> <volume>13</volume> (<issue>1</issue>), <fpage>118</fpage>. <pub-id pub-id-type="doi">10.1186/s12934-014-0118-z</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gorwa-Grauslund</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carlquist</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2014b</year>). <article-title>Exploiting cell metabolism for biocatalytic whole-cell transamination by recombinant <italic>Saccharomyces cerevisiae</italic>
</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>98</volume> (<issue>10</issue>), <fpage>4615</fpage>&#x2013;<lpage>4624</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-014-5576-z</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gorwa-Grauslund</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carlquist</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Improvement of whole-cell transamination with <italic>Saccharomyces cerevisiae</italic> using metabolic engineering and cell pre-adaptation</article-title>. <source>Microb. Cell. Fact.</source> <volume>16</volume> (<issue>1</issue>), <fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/s12934-016-0615-3</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Teixeira</surname>
<given-names>P. G.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Siewers</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Multidimensional engineering of <italic>Saccharomyces cerevisiae</italic> for efficient synthesis of medium-chain fatty acids</article-title>. <source>Nat. Catal.</source> <volume>3</volume> (<issue>1</issue>), <fpage>64</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-019-0409-1</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>